ClinicalTrials.Veeva

Menu

The Hip Fracture Surgical Approach Trial (HIFSAT)

D

Diakonhjemmet Hospital

Status

Enrolling

Conditions

Hip Fracture
Femoral Neck Fracture

Treatments

Procedure: Direct lateral approach
Procedure: SPAIRE

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The HIFSAT study will compare the standard direct lateral approach to hemiarthroplasty to a new muscle sparing approach (SPAIRE) in femoral neck fracture patients.

Full description

Femoral neck fractures are mostly treated with a hemiarthroplasty, where the fractured femoral head is replaced with a metal implant. The most common surgical approach to hemiarthroplasty has been the lateral approach, in which the gluteus medius tendon is partially released from the greater trochanter. Hip pain and limping is not uncommon after this approach has been used. A new surgical approach (SPAIRE) has been developed to alleviate this problem, and in this method the surgeon approaches the injured hip joint from posterior, preserving most of the muscles and tendons around the hip. This trial is designed to assess if this new SPAIRE approach leads to better results than the lateral approach in patients with femoral neck fractures.

Enrollment

406 estimated patients

Sex

All

Ages

50+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Femoral neck fracture
  • Clinical indication for hemiarthroplasty
  • Age over 50 years

Exclusion criteria

  • Previous hip implants in the same hip
  • Patients assessed to be in a terminal state with an expected survival of less than 1 week
  • Other factors that makes follow-up impossible

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

406 participants in 2 patient groups

Direct lateral approach
Active Comparator group
Treatment:
Procedure: Direct lateral approach
Spaire approach
Experimental group
Treatment:
Procedure: SPAIRE

Trial contacts and locations

1

Loading...

Central trial contact

Maren Paus, MD; Mads Sundet, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems